82 FR 43393 - National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 178 (September 15, 2017)

Page Range		43393-43394
FR Document		2017-19592

Federal Register, Volume 82 Issue 178 (Friday, September 15, 2017)

[Federal Register Volume 82, Number 178 (Friday, September 15, 2017)]
[Notices]
[Pages 43393-43394]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-19592]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Deafness and Other Communication Disorders; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Deafness and Other 
Communication Disorders Special Emphasis Panel; Chemical Senses 
Fellowship Review.
    Date: October 11, 2017.
    Time: 12:30 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health. Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Sheo Singh, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Division of Extramural Activities, 6001 
Executive Blvd., Room 8351, Bethesda, MD 20892, 301-496-8683, 
[email protected].


[[Page 43394]]


    Name of Committee: National Institute on Deafness and Other 
Communication Disorders Special Emphasis Panel; Hearing and Balance 
Fellowships Review.
    Date: October 16, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Shiguang Yang, DVM, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, NIDCD, NIH, 6001 
Executive Blvd., Room 8349, Bethesda, MD 20892, 301-496-8683, 
[email protected].

    Name of Committee: National Institute on Deafness and Other 
Communication Disorders Special Emphasis Panel; VSL Fellowship 
Review.
    Date: October 18, 2017.
    Time: 12:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Sheo Singh, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Division of Extramural Activities, 6001 
Executive Blvd., Room 8351, Bethesda, MD 20892, 301-496-8683, 
[email protected].

    Name of Committee: Communication Disorders Review Committee.
    Date: October 19, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Eliane Lazar-Wesley, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Institute on 
Deafness and other Communication Disorders/NIH, 6001 Executive 
Blvd., MSC 9670, Bethesda, MD 20892-8401, 301-496-8683 [email protected].

    Name of Committee: National Institute on Deafness and Other 
Communication Disorders Special Emphasis Panel; P50 Review.
    Date: October 26, 2017.
    Time: 11:00 a.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Kausik Ray, Ph.D., Scientific Review Officer, 
National Institute on Deafness and Other Communication Disorders, 
National Institutes of Health, Rockville, MD 20850, 301-402-3587, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.173, 
Biological Research Related to Deafness and Communicative Disorders, 
National Institutes of Health, HHS)

    Dated: September 8, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-19592 Filed 9-14-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 178 / Friday, September 15, 2017 / Notices 43393

Potential Commercial Applications: MD 20892, tel: 301–496–2644, fax: 240– No. PCT/US2017/021573 filed on 03/09/
• Therapeutics for hypertension 627–3117. A signed Confidential 2017.
• Therapeutics for anxiety disorders Disclosure Agreement will be required Licensing Contact: Chris Kornak, 240–
• Therapeutics for sleep disorders to receive copies of unpublished patent 627–3705, chris.kornak@nih.gov.
Development Stage: applications. Collaborative Research Opportunity:
• In vivo data available SUPPLEMENTARY INFORMATION: The Technology Transfer and
Inventors: George Kunos and Technology description follows. Intellectual Property Office (TTIPO) is
Alexandros Makriyannis (both of seeking parties interested in
NIAAA) Recombinant HIV-1 Envelope Proteins collaborative research to further develop
Intellectual Property: HHS Reference and Their Use the technology. In particular, NIAID is
No. E–211–2006/0–US–06. Description of Technology: Millions of interested in partnerships utilizing
• U.S. Patent 8,293,724 filed April 6, people are infected with HIV-1 vector vaccine platforms for expressing
2010, issued October 23, 2012. worldwide. In the U.S., there are about these immunogens.
Licensing Contact: Michael 30,000 new cases of HIV infection However, NIAID is willing to discuss
Shmilovich, Esq, CLP; 301–435–5019; reported annually. Currently, there are other applications of this technology.
shmilovm@nih.gov. effective, anti-retroviral therapeutics For collaboration opportunities, please
Collaborative Research Opportunity: available to treat or prevent HIV contact Chris Kornak, 240–627–3705,
The National Institute of Environmental infection. However, available anti- chris.kornak@nih.gov.
Health Sciences seeks statements of retroviral therapeutics require life-long Dated: September 7, 2017.
capability or interest from parties administration. Suzanne Frisbie,
interested in collaborative research to During infection, proteases of the host Deputy Director, Technology Transfer and
further develop and evaluate, please cell cleave gp160 into gp120 and gp41. Intellectual Property Office, National Institute
contact Peg Koelble, Office of Gp41 is an integral membrane protein, of Allergy and Infectious Diseases.
Technology Transfer, National Heart, while gp120 protrudes from the mature [FR Doc. 2017–19591 Filed 9–14–17; 8:45 am]
Lung and Blood Institute, koelblep@ virus. Together gp120 and gp41 BILLING CODE 4140–01–P
nhlbi.nih.gov, 301–594–4095. aggregate as trimers that make up the
Dated: September 7, 2017. HIV-1 envelope (‘‘Env’’) spike, which is
Michael Shmilovich, a target for neutralizing antibodies. DEPARTMENT OF HEALTH AND
NIAID researchers have constructed a HUMAN SERVICES
Senior Licensing and Patenting Manager,
National Heart, Lung, and Blood Institute,
recombinant HIV-1 trimer immunogen.
Office of Technology Transfer and In particular, the recombinant gp120 National Institutes of Health
Development. protein in the trimer is stabilized in a
[FR Doc. 2017–19590 Filed 9–14–17; 8:45 am] closed conformation, preventing it from National Institute on Deafness and
binding to CD4. The advantage of the Other Communication Disorders;
BILLING CODE 4140–01–P
closed conformation is that it can Notice of Closed Meetings
stabilize the epitopes that bind to Pursuant to section 10(d) of the
DEPARTMENT OF HEALTH AND broadly neutralizing antibodies, Federal Advisory Committee Act, as
HUMAN SERVICES minimize the binding of gp120 with amended, notice is hereby given of the
weakly or non-neutralizing antibodies, following meetings.
National Institutes of Health and prevent conformational changes The meetings will be closed to the
induced by CD4 as well as immunogen public in accordance with the
Government-Owned Inventions; sequestration by CD4 in vivo. Research provisions set forth in sections
Availability for Licensing has also indicated that recombinant Env 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
AGENCY: National Institutes of Health, ectodomain trimers can induce higher as amended. The grant applications and
HHS. neutralizing antibody titers than wild the discussions could disclose
type Env trimers in animal models. confidential trade secrets or commercial
ACTION: Notice. This technology is available for property such as patentable material,
SUMMARY: The inventions listed below licensing for commercial development and personal information concerning
are owned by an agency of the U.S. in accordance with 35 U.S.C. 209 and 37 individuals associated with the grant
Government and are available for CFR part 404, as well as for further applications, the disclosure of which
licensing to achieve expeditious development and evaluation under a would constitute a clearly unwarranted
commercialization of results of research collaboration. invasion of personal privacy.
federally-funded research and Potential Commercial Applications: Name of Committee: National Institute on
development. Foreign patent • HIV-1 immunogen Deafness and Other Communication
applications are filed on selected • New methods for isolating broadly Disorders Special Emphasis Panel; Chemical
inventions to extend market coverage neutralizing antibodies Senses Fellowship Review.
Competitive Advantages: Date: October 11, 2017.
for companies and may also be available
• A new strategy in inducing immune Time: 12:30 p.m. to 3:00 p.m.
for licensing.
response against HIV-1 Agenda: To review and evaluate grant
FOR FURTHER INFORMATION CONTACT: Development Stage: applications.
Chris Kornak, 240–627–3705, chris. • Pre-Clinical; Proof-of-concept Place: National Institutes of Health.
kornak@nih.gov. Licensing information studies in nonhuman primate Neuroscience Center, 6001 Executive
mstockstill on DSK30JT082PROD with NOTICES

and copies of the U.S. patent models Boulevard, Rockville, MD 20852 (Telephone
applications listed below may be Inventors: Conference Call).
obtained by communicating with the Contact Person: Sheo Singh, Ph.D.,
Paolo Lusso, NIAID, NIH
Scientific Review Officer, Scientific Review
indicated licensing contact at the Peng Zhang, NIAID, NIH Branch, Division of Extramural Activities,
Technology Transfer and Intellectual Publications: Pending. 6001 Executive Blvd., Room 8351, Bethesda,
Property Office (TTIPO), 5601 Fishers Intellectual Property: HHS Reference MD 20892, 301–496–8683, singhs@
Lane, Suite 6D, MSC 9804, Rockville, No. E–102–2016/0—PCT Application nidcd.nih.gov.

VerDate Sep<11>2014 17:07 Sep 14, 2017 Jkt 241001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\15SEN1.SGM 15SEN1

43394 Federal Register / Vol. 82, No. 178 / Friday, September 15, 2017 / Notices

Name of Committee: National Institute on Disorders, National Institutes of Health, request, including your address to:
Deafness and Other Communication Rockville, MD 20850, 301–402–3587, GarciaA@od.nih.gov. Formal requests
Disorders Special Emphasis Panel; Hearing rayk@nidcd.nih.gov. for additional plans and instruments
and Balance Fellowships Review. (Catalogue of Federal Domestic Assistance
Date: October 16, 2017.
must be requested in writing.
Program Nos. 93.173, Biological Research
Time: 8:00 a.m. to 5:00 p.m. Related to Deafness and Communicative SUPPLEMENTARY INFORMATION: Section
Agenda: To review and evaluate grant Disorders, National Institutes of Health, HHS) 3506(c)(2)(A) of the Paperwork
applications.
Dated: September 8, 2017. Reduction Act of 1995 requires: Written
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin Sylvia L. Neal,
comments and/or suggestions from the
Avenue, Bethesda, MD 20814. public and affected agencies are invited
Program Analyst, Office of Federal Advisory
Contact Person: Shiguang Yang, DVM, Committee Policy.
to address one or more of the following
Ph.D., Scientific Review Officer, Division of points: (1) Whether the proposed
[FR Doc. 2017–19592 Filed 9–14–17; 8:45 am]
Extramural Activities, NIDCD, NIH, 6001 collection of information is necessary
Executive Blvd., Room 8349, Bethesda, MD BILLING CODE 4140–01–P
for the proper performance of the
20892, 301–496–8683, yangshi@ function of the agency, including
nidcd.nih.gov.
DEPARTMENT OF HEALTH AND whether the information will have
Name of Committee: National Institute on practical utility; (2) The accuracy of the
Deafness and Other Communication HUMAN SERVICES
agency’s estimate of the burden of the
Disorders Special Emphasis Panel; VSL
Fellowship Review. National Institutes of Health proposed collection of information,
Date: October 18, 2017. including the validity of the
Time: 12:30 p.m. to 4:00 p.m. Proposed Collection; 60-Day Comment methodology and assumptions used; (3)
Agenda: To review and evaluate grant Request; Special Volunteer and Guest Ways to enhance the quality, utility, and
applications. Researcher Assignment (Office of clarity of the information to be
Place: National Institutes of Health, Intramural Research, Office of the collected; and (4) Ways to minimize the
Neuroscience Center, 6001 Executive Director) burden of the collection of information
Boulevard, Rockville, MD 20852 (Telephone
on those who are to respond, including
Conference Call). AGENCY: National Institutes of Health,
Contact Person: Sheo Singh, Ph.D., the use of appropriate automated,
HHS.
Scientific Review Officer, Scientific Review electronic, mechanical, or other
ACTION: Notice. technological collection techniques or
Branch, Division of Extramural Activities,
6001 Executive Blvd., Room 8351, Bethesda, SUMMARY: In compliance with the other forms of information technology.
MD 20892, 301–496–8683, singhs@ requirement of the Paperwork Proposed Collection Title: Special
nidcd.nih.gov. Reduction Act of 1995, for opportunity Volunteer and Guest Researcher
Name of Committee: Communication for public comment on proposed data Assignment form—Reinstatement
Disorders Review Committee. collection projects, the Office of
Date: October 19, 2017.
without Change of OMB #0925–0177,
Time: 8:00 a.m. to 5:00 p.m. Intramural Research (OIR), Office of the Office of Intramural Research (OIR),
Agenda: To review and evaluate grant Director (OD), National Institutes of Office of the Director (OD), National
applications. Health (NIH), will publish periodic Institutes of Health (NIH).
Place: Bethesda North Marriott Hotel & summaries of proposed projects to be Need and Use of Information
Conference Center, 5701 Marinelli Road, submitted to the Office of Management Collection: Form Number: NIH–590 is a
Bethesda, MD 20852. and Budget (OMB) for review and
Contact Person: Eliane Lazar-Wesley, single form completed by an NIH
approval. official for each Guest Researcher or
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute on DATES: Comments regarding this Special Volunteer prior to his/her
Deafness and other Communication information collection are best assured arrival at NIH. The information on the
Disorders/NIH, 6001 Executive Blvd., MSC of having their full effect if received form is necessary for the approving
9670, Bethesda, MD 20892–8401, 301–496– within 60 days of the date of this official to reach a decision on whether
8683 el6r@nih.gov. publication. to allow a Guest Researcher to use NIH
Name of Committee: National Institute on facilities, or whether to accept volunteer
FOR FURTHER INFORMATION CONTACT: To
Deafness and Other Communication services offered by a Special Volunteer.
Disorders Special Emphasis Panel; P50 obtain a copy of the data collection
plans and instruments, submit If the original assignment is extended,
Review.
Date: October 26, 2017. comments in writing, or request more another form notating the extension is
Time: 11:00 a.m. to 2:30 p.m. information on the proposed project, completed to update the file. In
Agenda: To review and evaluate grant contact: Dr. Arlyn Garcia-Perez, addition, each Special Volunteer and
applications. Assistant Director, Office of Intramural Guest Researcher reads and signs an
Place: National Institutes of Health, Research, Office of the Director, NIH Agreement.
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
National Institutes of Health, 1 Center OMB approval is requested for 3
Conference Call). Drive MSC 0140, Building 1, Room 160, years. There are no costs to respondents
Contact Person: Kausik Ray, Ph.D., MSC–0140, Bethesda, Maryland, 20892 other than their time. The total
Scientific Review Officer, National Institute or call non-toll-free number (301) 496– estimated annualized burden hours are
on Deafness and Other Communication 1921 or (301) 496–1381 or Email your 527.

ESTIMATED ANNUALIZED BURDEN HOURS
mstockstill on DSK30JT082PROD with NOTICES

Average
Number of Total annual
Number of burden per
Form name Type of respondents responses per hour burden
respondents response
respondent hours
(in hours)

Special Volunteer and Guest Re- Special Volunteers and Guest re- 2,870 1 6/60 287
searcher Assignment. searchers.

VerDate Sep<11>2014 17:07 Sep 14, 2017 Jkt 241001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\15SEN1.SGM 15SEN1

Document Created: 2017-09-15 00:18:38
Document Modified: 2017-09-15 00:18:38

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 11, 2017.
FR Citation		82 FR 43393

82 FR 43393 - National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 178 (September 15, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health